XML 37 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Event
9 Months Ended
Sep. 30, 2020
Subsequent Events [Abstract]  
Subsequent Event

15.

Subsequent Event

Milestone Payment to Humabs

In October 2020, the Company achieved one of the specified clinical milestones for the SARS-CoV-2 product under its acquisition agreement with Humabs and paid $10.0 million related to this milestone event. See Note 4—Acquisitions for additional information on the Company’s acquisition agreement with Humabs.